Crowdonomics
WatchlistPortfolio
Cao Pharmaceuticals Inc.15

Reg CF · Common Stock · May 2022

ClosedReg CFCommon Equity
via Silicon Prairie · last checked Aug 17, 2026
Raised
$0 / $5M max
0% of ceiling
Investors
—
—
Valuation
—
—

Financials disclosed in this offering

FY2020–FY2021 · hover for source
$0
−$604K
FY2020
$0
−$186K
FY2021
RevenueNet income
Metric
FY2020 audited*
FY2021 audited*
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$604,397
-$186,265
Taxes paid
$0
$0
Balance sheet
Cash
$78,415
$54,884
Accounts receivable
$0
$0
Total assets
$2,693,828
$2,662,118
Short-term debt
$2,878
$2,433
Long-term debt
$0
$0
Total liabilities
$2,878
$2,433
Other
Headcount
—
10

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

1 amendment
  1. May 13, 2022
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Price / share$1,000.00
Shares offered10,000

Offering details

Target$10,000
Max$5,000,000
Min investment—
OpenedMay 2, 2022
DeadlineApr 24, 2023
ClosedApr 24, 2023
Days active357

Links & provenance

SEC filing
Source: SEC EDGAR
0001784334-22-000001
Last synced Aug 17, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.